Log in

Relevant bibliographies by topics / Hepatitis C Viruses

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Hepatitis C Viruses'

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatitis C Viruses.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatitis C Viruses"

1

Salam, Abdul, Bilqis Aslam Baloch, Naseer Khan, Ghulam Sarwar, and Masoom ,. "SEROPREVALENCE OF HBsAg (HBS) AND ANTI-HCV." Professional Medical Journal 21, no. 04 (2018): 766–70. http://dx.doi.org/10.29309/tpmj/2014.21.04.2424.

Full text

Abstract:

Background: Hepatitis is the inflammation of liver caused by infectious and noninfectiousagents. Hepatitis B and C are inflammations of liver caused by the viruses which are themajor public health problems worldwide and the incidence is even more in our country.Objective: Objective of the study was, 1). To estimate the prevalence of hepatitis B and hepatitisC viruses infected persons among the general population coming to BMC Hospital. 2). To pointout the more affected area of Baluchistan. 3). To produce awareness in the people. 4). To bringthis issue in Government notice. Method: The data was

APA, Harvard, Vancouver, ISO, and other styles

2

Sperandeo, M., A. Varriale, G. Sperandeo, and R. Morante. "Hepatitis B and hepatitis C viruses and alcoholism." Journal of Hepatology 13 (January 1991): S173. http://dx.doi.org/10.1016/0168-8278(91)91665-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

W Smith, David. "Sexual transmission of hepatitis viruses." Microbiology Australia 28, no. 1 (2007): 20. http://dx.doi.org/10.1071/ma07019.

Full text

Abstract:

Hepatitis viruses are often not perceived as sexually transmitteddiseases, but sex is an extremely important mode of transmission worldwide for hepatitis B, and it plays a significant role for hepatitis C, hepatitis A and hepatitis D.

APA, Harvard, Vancouver, ISO, and other styles

4

Pinho, João Renato Rebello, and Luiz Caetano da Silva. "GB virus C/Hepatitis G virus and other putative hepatitis non A-E viruses." Revista do Instituto de Medicina Tropical de São Paulo 38, no. 6 (1996): 441–50. http://dx.doi.org/10.1590/s0036-46651996000600010.

Full text

Abstract:

The identification of the major agents causing human hepatitis (Hepatitis A, B, C, D and E Viruses) was achieved during the last 30 years. These viruses are responsible for the vast majority of human viral hepatitis cases, but there are still some cases epidemiologically related to infectious agents without any evidence of infection with known virus, designated as hepatitis non A - E. Those cases are considered to be associated with at least three different viruses: 1 - Hepatitis B Virus mutants expressing its surface antigen (HBsAg) with altered epitopes or in low quantities; 2 - Another viru

APA, Harvard, Vancouver, ISO, and other styles

5

A White, Peter. "Recent breakthroughs to combat Hepatitis C virus infection." Microbiology Australia 26, no. 1 (2005): 12. http://dx.doi.org/10.1071/ma05012.

Full text

Abstract:

Following the discovery of hepatitis A and B viruses, it was almost certain that a third virus also attacked the liver. The main criteria for this thinking was the fact that, following blood transfusion, hepatitis with slightly different clinical features occurred in patients who were negative for both viruses, hence the disease was known as non-A, non-B post-transfusion hepatitis.

APA, Harvard, Vancouver, ISO, and other styles

6

Yan, Brian M., and Samuel S. Lee. "Acute Coinfection with Hepatitis B and Hepatitis C Viruses." Canadian Journal of Gastroenterology 19, no. 12 (2005): 729–30. http://dx.doi.org/10.1155/2005/514813.

Full text

Abstract:

Acute coinfection of hepatitis B virus (HBV) and hepatitis C virus (HCV) is rare. The few previously reported cases all describe acute HBV followed by acute HCV, leading to HBV clearance but chronic HCV. This is the first reported case of acute concurrent infection and spontaneous clearance of both HBV and HCV.

APA, Harvard, Vancouver, ISO, and other styles

7

Curry, Michael P. "Hepatitis B and Hepatitis C Viruses in Liver Transplantation." Transplantation 78, no. 7 (2004): 955–63. http://dx.doi.org/10.1097/01.tp.0000140927.63952.58.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Wieland, Stefan F., and Francis V. Chisari. "Stealth and Cunning: Hepatitis B and Hepatitis C Viruses." Journal of Virology 79, no. 15 (2005): 9369–80. http://dx.doi.org/10.1128/jvi.79.15.9369-9380.2005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Golkocheva-Markova, Elitsa, and Lilia Ganova-Raeva. "Editorial: Epidemiology and Control of Hepatitis Viruses." Life 14, no. 11 (2024): 1369. http://dx.doi.org/10.3390/life14111369.

Full text

Abstract:

Five hepatitis viruses—hepatitis A (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and hepatitis E (HEV)—have a huge impact on human health with their ability to cause acute and often chronic infection [...]

APA, Harvard, Vancouver, ISO, and other styles

10

Gurtsevitch, V. E. "Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis." Biochemistry (Moscow) 73, no. 5 (2008): 504–13. http://dx.doi.org/10.1134/s0006297908050039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Hepatitis C Viruses"

1

Oni, Oluropo Ayodele. "Genotypes of hepatitis B and C viruses in Nigeria." Thesis, University College London (University of London), 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243523.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Beer, Melanie. "Hepatocellular lipid metabolism in Hepatitis C Virus infection." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:799c17b6-2b2c-480f-ae89-6730d7e5b332.

Full text

Abstract:

The work described in this thesis investigates the lipid metabolism of human hepatocytes in the context of Hepatitis C Virus (HCV) infection. This includes lipoprotein signalling and cholesterol metabolism targeted analysis of gene expression as well as the influence of polyunsaturated ER targeting liposomes (PERLs) on infection. These analyses indicate that HCV suppresses the expression of key regulators throughout the cholesterol biosynthesis pathway. This effect was quantified and the influence of liposome treatment evaluated. The latter resulted in the formulation of the hypothesis that PE

APA, Harvard, Vancouver, ISO, and other styles

3

Selvamani, Sakthi. "Effect of Hepatitis B and C Viruses on Mitochondrial Function." Thesis, University of Sydney, 2020. https://hdl.handle.net/2123/24376.

Full text

Abstract:

HCV and HBV infections are leading causes of chronic hepatitis, cirrhosis, and hepatocellular carcinoma and can induce metabolic dysfunction, which may offer a selective advantage for liver cancer proliferation and survival. The liver is enriched with numerous mitochondria, providing a continuous supply of ATP for a range of cellular activities. The hypothesis of this thesis is that HBV and HCV induce mitochondrial dysfunction and metabolic disorders. A range of cell culture models and in vitro techniques were used to test this hypothesis, including the Seahorse analyser to measure mitochondr

APA, Harvard, Vancouver, ISO, and other styles

4

Razali, Karina National Centre in HIV Epidemiology &amp Clinical Research Faculty of Medicine UNSW. "Estimates and projections of HIV and Hepatitis C virus in Australia and the Asia-Pacific region." Publisher:University of New South Wales. National Centre in HIV Epidemiology & Clinical Research, 2008. http://handle.unsw.edu.au/1959.4/41095.

Full text

Abstract:

The use of mathematical models in studying disease epidemics can be diverse, from the focused study of the role of a single determinant of the epidemic, or to the overall estimation of morbidity and mortality. In using simple deterministic models, a balance is struck between biological and social complexities, and the high data input demands of mathematical models. This thesis aims to apply the use of deterministic mathematical models to the studies of HIV and hepatitis C epidemiology in the Asia-Pacific region. In Australia, about 85% of reported HIV cases are among homosexual men. Casual

APA, Harvard, Vancouver, ISO, and other styles

5

Tuplin, Andrew. "Prediction of RNA secondary structure in hepatitis C and related viruses." Thesis, University of Edinburgh, 2004. http://hdl.handle.net/1842/27558.

Full text

Abstract:

The existence of functional importance of RNA secondary structure in the replication of positive-stranded RNA viruses is increasingly recognised. In this thesis several computational methods to detect RNA secondary structure in the coding regions of hepatitis C virus (HCV), hepatitis G virus (HGV)/GB virus C (GBV-C) and related viruses have been used. These include thermodynamic prediction of folding free energies (FFEs), evolutionary conservation of minimum energy structures between virus genotypes, suppression of synonymous variability and analysis of covariant and semi covariant substitutio

APA, Harvard, Vancouver, ISO, and other styles

6

Tucker, Timothy Johan Paul. "Epidemiology, molecular characterisation and tropism of the Hepatitis G Virus / GBV-C." Doctoral thesis, University of Cape Town, 1999. http://hdl.handle.net/11427/25669.

Full text

Abstract:

The hepatitis G virus and GBV-C are recently discovered variants of the same virus belonging to the family Flavivirus (HGV/GBV-C). Although initially thought to be a hepatitis virus, it has been shown to have no association with liver disease. No work has been performed on the prevalence or molecular characteristics of HGV/GBV-C in southern Africa. In addition, although it is clear that the liver is not the primary site of replication, there is no data on the sites of HGV/GBV-C replication in normal subjects. Thus, this study aimed to assess the prevalence of HGV/GBV-C carriage in the urban an

APA, Harvard, Vancouver, ISO, and other styles

7

Liu, Yip-mei. "Sero-prevalence of hepatitis A, B, C and D viruses in Hong Kong." Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25176535.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sallam, Talal Abdul Malik. "Studies of the 'core' proteins of the hepatitis C and G viruses." Thesis, University of Liverpool, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

廖葉媚 and Yip-mei Liu. "Sero-prevalence of hepatitis A, B, C and D viruses in Hong Kong." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B31970710.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Горбачевський, Артем Олександрович, Артем Александрович Горбачевский, Artem Oleksandrovych Horbachevskyi, Микола Дмитрович Чемич, Николай Дмитриевич Чемич, and Mykola Dmytrovych Chemych. "Variability of complications of liver cirrhosis associated with hepatitis B and C viruses." Thesis, Lithuanian University of Health Sciences, 2020. https://essuir.sumdu.edu.ua/handle/123456789/81411.

Full text

Abstract:

Серед обстежених 84% випадків були розподілені наступним чином: вірусний гепатит С, вірусний гепатит В 7,4% супутня інфекція В + Г 5,6%. В обстеженій групі переважали чоловіки (62,9%) та жителі міста (70,4%), середній вік пацієнтів становив 44,2 ± 0,2 року. Ймовірний шлях зараження: під час медичних втручань (18,5%); вживання внутрішньовенних препаратів, донорство (по 7,4%); стоматологічні процедури (11,1%); переливання крові або його складові (5,5%); професійна діяльність (медичні працівники) (1,8%); не визначено - у 48,3% опитуваних. Пацієнти з мінімальною активністю (68,5%) були в 3,7 рази

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Hepatitis C Viruses"

1

Hagedorn, Curt H., and Charles M. Rice, eds. The Hepatitis C Viruses. Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-59605-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

W, Reesink H., ed. Hepatitis C virus. 2nd ed. Karger, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

W, Reesink H., ed. Hepatitis C virus. Karger, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

National Institutes of Health (U.S.). Continuing Medical Education. and National Institutes of Health Consensus Development Conference on Management of Hepatitis C (1997 : Bethesda, Md.), eds. Management of hepatitis C: March 24-26, 1997. National Institutes of Health, Continuing Medical Education, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hengli, Tang, ed. Hepatitis C methods and protocols. 2nd ed. Humana Press, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sasagawa, Shigeru. Mijika na ketsueki zemināru: Eizu C-gata kanʼen, ketsuekigata kara yuketsu made. Kōdansha, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Great Britain. Department of Health., ed. Hepatitis C infected health care workers: [implementing "Getting ahead of the curve: action on blood-borne viruses"]. DOH, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

1965-, Southgate Erica, and Australian National Council on Drugs., eds. Dealing with risk: A multidisciplinary study of injecting drug use, hepatitis C and other blood-borne viruses in Australia. Australian National Council on Drugs, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sawyer, Forrest. Hepatitis C. Films for the Humanities & Sciences, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Shiffman, Mitchell L., ed. Chronic Hepatitis C Virus. Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-1192-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Hepatitis C Viruses"

1

Perumalswami, Ponni V., and Robert S. Klein. "Hepatitis Viruses: Hepatitis C." In Viral Infections of Humans. Springer US, 2014. http://dx.doi.org/10.1007/978-1-4899-7448-8_33.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Blight, Keril J., Arash Grakoui, Holly L. Hanson, and Charles M. Rice. "The Molecular Biology of Hepatitis C Virus." In Hepatitis Viruses. Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0881-6_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wong, David K. H., and Bruce D. Walker. "Hepatitis C Virus." In Human Tumor Viruses. ASM Press, 2014. http://dx.doi.org/10.1128/9781555818289.ch10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Jacobson, I. M. "Hepatitis C therapy." In Liver under Constant Attack — From Fat to Viruses. Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-2759-7_3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Lindenbach, Brett. "Hepatitis C Virus and Hepatocellular Carcinoma." In Cancer Associated Viruses. Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-0016-5_23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nolte, Frederick S. "Hepatitis B and C Viruses." In Molecular Pathology in Clinical Practice: Infectious Diseases. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-87369-5_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Nolte, Frederick S. "Hepatitis B and C Viruses." In Molecular Pathology in Clinical Practice. Springer New York, 2007. http://dx.doi.org/10.1007/978-0-387-33227-7_37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Nolte, Frederick S. "Hepatitis B and C Viruses." In Molecular Pathology in Clinical Practice. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-19674-9_46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ferrari, C. "Hepatitis C virus immunology." In Liver under Constant Attack — From Fat to Viruses. Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-2759-7_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Kurstak, Edouard. "Hepatitis C and hepatitis E viruses: epidemiology and transmission." In Viral Hepatitis. Springer Vienna, 1993. http://dx.doi.org/10.1007/978-3-7091-4437-4_21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hepatitis C Viruses"

1

Rabbi, Md Anayt, Tania Alam Suchi, Md Manowarul Islam, Arnisha Akhter, and Md Ashraf Uddin. "An Effective Machine Learning Framework for Hepatitis C Virus Prediction." In 2024 IEEE International Conference on Biomedical Engineering, Computer and Information Technology for Health (BECITHCON). IEEE, 2024. https://doi.org/10.1109/becithcon64160.2024.10962606.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Remita, Amine M., and Abdoulaye Banire Diallo. "Statistical Linear Models in Virus Genomic Alignment-free Classification: Application to Hepatitis C Viruses." In 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). IEEE, 2019. http://dx.doi.org/10.1109/bibm47256.2019.8983375.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Cox, Andrea L. "Abstract IA16: Prevention of hepatocellular carcinoma through preventative hepatitis C vaccination." In Abstracts: AACR Special Conference on the Microbiome, Viruses, and Cancer; February 21-24, 2020; Orlando, FL. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.mvc2020-ia16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sivov, I. G., and I. S. Firsov. "FLECK QUANTIFICATION OF THE NUMBER OF INFECTIOUS SARS-COV-2 CORONAVIRUS PARTICLES." In Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-173.

Full text

Abstract:

The principle of obtaining sensors for detecting infectious particles of RNA viruses in samples was proposed for the diagnosis of infectious particles SARS-CoV-2. Previously, the similar sensor pattern was successfully applied in relation to the hepatitis C virus. It was founded that the ratio of the RNA titer, determined in the RT-PCR reaction in Real Time mode, refers to the number of infectious («shine») centers formed on the cell sensor culture, approximately as 100: 1, in the «coronavirus-positive» sample.

APA, Harvard, Vancouver, ISO, and other styles

5

Naif, Ali Nasir, Abdul Amir H. Kadhum, Uday Abdul-Reda Hussein, Ahmed A. Al-Amiery, Thaer Al-Jadir, and Mohammed Muayad Taha. "Prevalence and risk factors for hepatitis C and B viruses infection among hemodialysis patients in Iraq." In INTERNATIONAL CONFERENCE ON SCIENTIFIC RESEARCH & INNOVATION (ICSRI 2022). AIP Publishing, 2023. http://dx.doi.org/10.1063/5.0150759.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Matula, Petr, Anil Kumar, Ilka Wörz, et al. "Automated analysis of siRNA screens of cells infected by hepatitis C and dengue viruses based on immunofluorescence microscopy images." In Medical Imaging, edited by Xiaoping P. Hu and Anne V. Clough. SPIE, 2008. http://dx.doi.org/10.1117/12.770778.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Trishna, Tahira Islam, Shimoul Uddin Emon, Romana Rahman Ema, Gazi Imran Hossen Sajal, Shuvodip Kundu, and Tajul Islam. "Detection of Hepatitis (A, B, C and E) Viruses Based on Random Forest, K-nearest and Naïve Bayes Classifier." In 2019 10th International Conference on Computing, Communication and Networking Technologies (ICCCNT). IEEE, 2019. http://dx.doi.org/10.1109/icccnt45670.2019.8944455.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Schimpf, K. l., B. Kraus, W. Kreuz, H. H. Brackmann, F. Haschke, and W. Schramm. "NO ANTI-HIV SEROCONVERSION AFTER REPLACEMENT THERAPY WITH PASTEURIZED F VIII CONCENTRATE. A STUDY OF 151 PATIENTS WITH HEMOPHILIA A OR VON WILLEBRAND'S DISEASE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643973.

Full text

Abstract:

Transmission of hepatitis viruses and HIV has proven to be a risk of replacement therapy in hemophilia. As regards F VIII products a concentrate (Hemate HS or P) in which viruses are inactivated by heat-treatment over 10 hours at 60° C in aqueous solution is available since 1979. Our clinical studies have shown that this product does not transmit HBV and HNANBV. As the product was manufactured by 80% from US plasma it was necessary to prove that it also does not transmit HIV. As it is, for ethical reasons, not possible to treat a control group with non-virus-inactivated F VIII, non-transmissio

APA, Harvard, Vancouver, ISO, and other styles

9

Holanda, Arthur Cesário de, Daniel Alves de Oliveira, Vitor Maia Arca, et al. "Acute cerebellar ataxia due to Dengue fever: case presentation and four-year follow-up." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.603.

Full text

Abstract:

Case presentation: A 70-year-old female was admitted due to imbalance associated to high fever, headache, photophobia, myalgia, and emesis for 5 days. She denied other symptoms or predisposing agents. At examination, there was a global asymmetric cerebellar syndrome, without other findings. Laboratory work-up showed lymphocytosis, leucopenia, thrombocytopenia, and increased liver enzymes. Serologic exams were negative for syphilis, HIV, hepatitis B and C viruses, CMV, rubella, toxoplasmosis, and trypanosomiasis in peripheral blood, and for CMV, herpes simplex and varicella-zoster viruses, and

APA, Harvard, Vancouver, ISO, and other styles

10

Eid, Fatma Elzahraa, Haitham Elmarakeby, Lenwood Heath, and Mahmoud ElHefnawi. "Human microRNAs targeting hepatitis C virus." In 2014 Middle East Conference on Biomedical Engineering (MECBME). IEEE, 2014. http://dx.doi.org/10.1109/mecbme.2014.6783236.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Hepatitis C Viruses"

1

Sjogren, Maria H., and Kent Holtzmuller. Hepatitis C Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada406083.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sjogren, Maria H. Hepatitis C. Virus Infection: Mechanism of Disease Progression. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada433067.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Sjogren, Maria H., and Brooke Huntley. Hepatitis C. Virus Infection: Mechanisms of Disease Progression. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada477987.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Ely, Danielle, and Gregory Elizabeth C.W. Trends and Characteristics in Maternal Hepatitis C Virus Infection Rates During Pregnancy: United States, 2016–2021. National Center for Health Statistics (U.S.), 2023. http://dx.doi.org/10.15620/cdc:124659.

Full text

Abstract:

This report presents data on trends for hepatitis C virus infection among mothers giving birth in the United States from 2016 through 2021, and rates by selected maternal characteristics for 2016, 2020, and 2021.

APA, Harvard, Vancouver, ISO, and other styles

5

Koizumi, Yoshiki, Syo Nakajim, Hirofumi Ohash, et al. Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection. Office of Scientific and Technical Information (OSTI), 2016. http://dx.doi.org/10.2172/1242919.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Nelson, David, Michael Fried, Mark Sulkowski, et al. Comparing Oral Medicines to Treat Hepatitis C Virus -- The PRIORITIZE Study. Patient-Centered Outcomes Research Institute® (PCORI), 2022. http://dx.doi.org/10.25302/03.2022.hpc.150327891.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Talal, Andrew, Marianthi Markatou, Ponni Perumalswami, et al. Facilitated Telemedicine for Underserved Populations: Management of Chronic Hepatitis C Virus Infection. The TEAM-C Study. Patient-Centered Outcomes Research Institute (PCORI), 2025. https://doi.org/10.25302/04.2025.ihs.150731640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lyons, Megan, Thomas Bennett, Felicia Gray-Hamilton, and Margaret Harvey. Hepatitis C Virus Screening Strategies to Improve Early Identification and Treatment: A Scoping Review. University of Tennessee Health Science Center, 2023. http://dx.doi.org/10.21007/con.dnp.2023.0046.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Litwin, Alain. Patient-Centered Hepatitis C Virus Care for People Who Inject Drugs -- The HERO Study. Patient-Centered Outcomes Research Institute (PCORI), 2024. http://dx.doi.org/10.25302/05.2024.hpc.150328122ic.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tangkijvanith, Pisit. Prevalence and Clinical Significance of Hepatitis B Viral Genotypes and Mutations. Faculty of Medicine, Chulalongkorn University, 2006. https://doi.org/10.58837/chula.res.2006.24.

Full text

Abstract:

Hepatitis B virus (HBV) infection is a major public health problem, with more than 400 million HBV carriers estimated worldwide. Chronic HBV infection is associated with a diverse clinical spectrum of liver damage ranging from asymptomatic carrier status, chronic hepatitis, cirrhosis, and hepatocellular carcinoma (HCC). There have been increasing lines of evidence to indicate influences of HBV genotypes and mutations on the outcome of liver disease, particularly the development of HCC. The project is aimed to study the prevalence and clinical significance of genotypes and mutations in Precore/

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!